HLA Class II Tissue Typing for Patient at Chughtai Lab

HLA Class II Tissue Typing for Patient at Chughtai Lab

Human Leukocyte Antigen (HLA) Class II Tissue Typing is a highly specialized molecular diagnostic test that identifies specific genetic markers on the surface of immune cells. These markers, encoded by the Major Histocompatibility Complex (MHC) genes on chromosome 6, play a fundamental role in the body’s immune response. Specifically, HLA Class II molecules (including HLA-DR, HLA-DQ, and HLA-DP) are primarily expressed on professional antigen-presenting cells such as dendritic cells, macrophages, and B lymphocytes. At Chughtai Lab, Pakistan’s premier diagnostic network, we utilize state-of-the-art molecular biology techniques to perform high-resolution HLA Class II typing, providing critical data for organ transplantation, bone marrow donor matching, and the diagnosis of various autoimmune disorders.

The clinical importance of HLA Class II tissue typing cannot be overstated. Unlike HLA Class I molecules, which are present on almost all nucleated cells, Class II molecules are central to initiating the helper T-cell response. When a foreign antigen is introduced into the body, antigen-presenting cells process it and present it via HLA Class II molecules to CD4+ T-helper cells. This interaction is the cornerstone of immune recognition. In the context of transplantation, if the recipient’s immune system recognizes the donor’s HLA Class II molecules as foreign, it will trigger a robust and potentially catastrophic immune response, leading to graft rejection or graft-versus-host disease (GVHD). Therefore, precise matching of these alleles between donors and recipients is essential to ensure long-term graft survival and patient safety.

Beyond transplantation, HLA Class II typing serves as a powerful diagnostic aid in clinical immunology. Certain HLA Class II alleles are strongly associated with an increased susceptibility to specific autoimmune diseases. For instance, the HLA-DQ2 and HLA-DQ8 alleles are highly correlated with Celiac disease, while specific HLA-DRB1 alleles are linked to Rheumatoid Arthritis and Multiple Sclerosis. By identifying these genetic predispositions, clinicians can make more accurate diagnoses, predict disease progression, and tailor personalized treatment strategies for patients across Pakistan.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of accuracy and prevent any potential interference with the molecular testing process, patients are advised to follow these preparation guidelines:

• No Fasting Required: Patients do not need to fast before undergoing HLA Class II Tissue Typing. You may eat and drink normally prior to your appointment.
• Medication Disclosure: Inform your physician and the Chughtai Lab staff of all medications, immunosuppressants, or biological therapies you are currently taking.
• Transfusion History: It is critical to disclose if you have received a blood transfusion or a bone marrow transplant within the last three months, as donor white blood cells can temporarily interfere with DNA extraction and typing results.
• Hydration: Staying well-hydrated is recommended to facilitate easier venous access during the blood collection process.
• Identification: Bring your official referral slip, national identity card (CNIC), and any previous transplant-related documentation to the lab.

During the Procedure

The collection of the sample for HLA Class II Tissue Typing is a straightforward and minimally invasive procedure. Here is what you can expect during your visit to Chughtai Lab:

• Aseptic Technique: A certified phlebotomist will clean the skin over a vein in your arm (usually the antecubital fossa) with an antiseptic solution to prevent contamination.
• Venipuncture: A sterile, single-use needle will be inserted into the vein to collect a whole blood sample. The blood is drawn directly into an EDTA (lavender-top) tube, which contains an anticoagulant necessary for preserving cellular DNA.
• Sample Labeling: The tube is immediately labeled with your unique patient identification details, barcoded, and prepared for transport to our specialized molecular pathology division under strict temperature-controlled conditions.
• Duration: The blood draw itself takes less than five minutes. However, the molecular analysis in the laboratory involves complex DNA extraction, amplification, and sequencing, which requires several days to complete.
• Safety and Comfort: The procedure is highly safe with minimal discomfort, similar to a standard blood test. Some patients may experience mild bruising or soreness at the injection site, which typically resolves within a day.

When is an HLA Class II Tissue Typing Performed?

Renal and Solid Organ Transplantation Matching

HLA Class II Tissue Typing is routinely performed before any solid organ transplant, particularly kidney transplants. Nephrologists and transplant surgeons require detailed HLA-DR and HLA-DQ matching to evaluate the immunological compatibility between the donor and the recipient. A closer match significantly reduces the risk of acute or chronic antibody-mediated rejection, minimizes the need for high-dose immunosuppressive therapy post-transplant, and extends the overall lifespan of the transplanted organ.

Hematopoietic Stem Cell and Bone Marrow Transplantation

In bone marrow or hematopoietic stem cell transplantation (HSCT) for leukemia, lymphoma, or aplastic anemia, HLA Class II matching is critical. Because the donor’s immune system is being transplanted into the recipient, any mismatch in HLA Class II alleles (especially HLA-DRB1 and HLA-DQB1) can cause the donor’s immune cells to attack the recipient’s tissues, a life-threatening condition known as Graft-Versus-Host Disease (GVHD). High-resolution molecular typing ensures the safest possible match.

Diagnostic Evaluation of Celiac Disease Predisposition

Gastroenterologists frequently order HLA Class II typing when evaluating patients with suspected Celiac disease, especially when serological tests or duodenal biopsies yield ambiguous results. The absence of HLA-DQ2 and HLA-DQ8 alleles has an extremely high negative predictive value (nearly 99%), meaning that if a patient does not carry these specific Class II markers, Celiac disease can be confidently ruled out as the cause of their gastrointestinal symptoms.

Assessment of Autoimmune Disease Susceptibility

Physicians utilize HLA Class II typing to assist in the diagnosis and risk stratification of several autoimmune conditions. For example, specific HLA-DRB1 alleles (known as the “shared epitope”) are associated with severe, erosive Rheumatoid Arthritis. Similarly, HLA-DRB1*15:01 is a known genetic risk factor for Multiple Sclerosis. Identifying these markers helps rheumatologists and neurologists understand the genetic component of a patient’s disease and manage their symptoms more proactively.

Investigating Drug Hypersensitivity and Pharmacogenomics

Certain HLA Class II alleles are linked to severe, drug-induced hypersensitivity reactions. Before prescribing specific high-risk medications, clinicians may request HLA typing to screen patients for genetic predispositions to adverse drug reactions. This proactive approach prevents severe systemic complications, such as drug-induced liver injury or severe cutaneous adverse reactions, ensuring safer therapeutic interventions.

What Does an HLA Class II Tissue Typing Detect?

HLA Class II Tissue Typing utilizes advanced molecular techniques to detect the presence of specific alleles across the major Class II loci. The test identifies variations within the highly polymorphic regions of the following genes:

• HLA-DRB1 Alleles: Detects specific variants such as HLA-DRB1*03:01, HLA-DRB1*04:01, HLA-DRB1*11:01, and HLA-DRB1*15:01, which are critical for transplant matching and are linked to Rheumatoid Arthritis, Multiple Sclerosis, and Lupus.
• HLA-DQB1 Alleles: Identifies alleles like HLA-DQB1*02:01, HLA-DQB1*03:02, and HLA-DQB1*06:02. These are essential for assessing Celiac disease susceptibility and Narcolepsy risk.
• HLA-DQA1 Alleles: Detects the alpha-chain variants of the HLA-DQ molecule, which pair with beta-chains to form functional receptors involved in antigen presentation.
• HLA-DPB1 Alleles: Identifies polymorphisms at the DP locus, which are increasingly recognized as important factors in matching for unrelated donor bone marrow transplants.
• Donor-Recipient Histocompatibility: Determines the exact degree of genetic mismatch (e.g., 0/6, 3/6, or 6/6 match) between a transplant candidate and a prospective living or deceased donor.
• Maternal-Fetal Incompatibility Markers: Helps evaluate cases of recurrent pregnancy loss or neonatal alloimmune thrombocytopenia where parental HLA sharing or incompatibility may play a role.
• Genetic Predisposition Profiles: Provides a comprehensive map of the patient’s immune-response genes, allowing specialists to calculate relative risk scores for various autoimmune and inflammatory syndromes.

Turnaround Time and Report Access at Chughtai Lab

Because HLA Class II Tissue Typing involves intricate DNA extraction, polymerase chain reaction (PCR) amplification, and high-resolution sequence-specific testing, the processing time is longer than standard blood tests. At Chughtai Lab, we prioritize accuracy and quality control at every stage of the molecular analysis. Typically, HLA typing reports are finalized within 7 to 10 working days.

Once the report is signed off by our consultant molecular pathologists, patients are notified via SMS. Reports can be easily accessed and downloaded online through the official Chughtai Lab website or our dedicated mobile application. Patients can also collect physical copies of their reports from any of our numerous collection centers located across Pakistan.

HLA Class II Tissue Typing Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HLA-DRB1 Locus	Presence of standard, non-risk associated DRB1 alleles.	Detection of HLA-DRB1*15:01 (Multiple Sclerosis risk) or HLA-DRB1*04 (Rheumatoid Arthritis risk).
HLA-DQB1 Locus	Absence of disease-associated DQB1 alleles.	Presence of HLA-DQB1*02:01 or *03:02 (High susceptibility to Celiac disease).
HLA-DPB1 Locus	Standard alleles compatible with general population distribution.	Mismatched DPB1 alleles in a transplant pair, increasing GVHD risk.
Donor-Recipient Match Grade	High compatibility (e.g., 6/6 or 8/8 allelic match across Class I and II).	Low compatibility or high mismatch grade, indicating a high risk of graft rejection.
Panel Reactive Antibodies (PRA) Correlation	No pre-existing antibodies against identified HLA Class II alleles.	Presence of donor-specific antibodies (DSA) targeting the recipient’s HLA Class II profile.
Gene Allelic Diversity	Heterozygous expression of standard maternal and paternal alleles.	Homozygosity or rare allelic variants that complicate finding a compatible transplant donor.
Antigen-Presenting Capability	Normal structural configuration of the peptide-binding groove.	Structural mutations affecting antigen presentation (extremely rare clinical presentations).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for HLA Class II Tissue Typing?

• Experienced Healthcare Professionals: Our molecular pathology department is led by highly qualified consultant pathologists and geneticists with extensive experience in immunogenetics.
• Advanced Molecular Technology: We utilize cutting-edge PCR-SSO and high-resolution sequencing technologies to ensure maximum typing accuracy.
• ISO 15189 Certified Processes: Chughtai Lab adheres to stringent international quality standards, ensuring reliable and reproducible results.
• Comprehensive Transplant Support: We work closely with major transplant centers across Pakistan to provide timely and precise matching services.
• Convenient Home Sample Collection: Patients can avail of our professional home sample collection service, bringing specialized diagnostics to their doorstep.
• Nationwide Network: With presence in all major cities of Pakistan, accessing our diagnostic services is convenient and hassle-free.
• Secure Online Report Portal: Retrieve your results instantly through our user-friendly website or mobile app, maintaining complete data privacy.
• Patient-Focused Care: We are committed to providing compassionate, professional, and clear guidance to patients navigating complex diagnostic journeys.